The e4Risk®is a non-genetic, cost-effective, and highly reliable method to detect the presence of the protein ApoE4 in human blood plasma by turbidimetry, using high-throughput chemistry analyzers.
e4Risk®is a turbidimetry-based assay with excellent performance in the context of the hospital/clinical settings (100% sensitivity and 99% specificity).
e4Risk®is a product with CE Marking. The process of obtaining the FDA approval is currently ongoing.
*Test based on patent nº EP 3274725 (European patent granted): “Method for apolipoprotein detection”
If you have any questions or comments, we will be pleased to attend you
If you have any questions or comments,
we will be pleased to attend you